title: [Psoriasis arthritis. An interdisciplinary challenge].
abstract: Psoriatic arthritis (PsA) is classified as a spondylarthropathy based on its clinical and serological characteristics. The clinical manifestations and the association with psoriasis or nail psoriasis have led, together with immunological characteristics, to a further differentiation. The pathophysiological and genetic understanding of this disease has advanced as a result of the development of new treatment strategies and targets in rheumatology and dermatology. Collaborative efforts and increasing multidisciplinary cooperation between rheumatologists and dermatologists have led to an increased awareness in early diagnosis and treatment. New treatment modalities have demonstrated significant efficacy in preventing radiologic progression resulting in amelioration of clinical symptoms, improvement of function and quality of life.
authors.affiliation: Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen, Competenzzentrum Versorgungsforschung in der Dermatologie, Universitätsklinikum Hamburg-Eppendorf. m.radtke@uke.de
authors.forename: M A
authors.initials: MA
authors.lastname: Radtke
authors.forename: K
authors.initials: K
authors.lastname: Reich
authors.forename: F
authors.initials: F
authors.lastname: Beikert
authors.forename: M
authors.initials: M
authors.lastname: Augustin
mesh_terms: D000465:Algorithms; D018501:Antirheumatic Agents / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D003299:Cooperative Behavior; D042241:Early Diagnosis; D061345:Early Medical Intervention; D020022:Genetic Predisposition to Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D033183:Interdisciplinary Communication
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents